Uterine Malignomas

Rare tumour entities in women
Both of these rare tumour entities in women as well as their precursors are often HPV positive. An HPV vaccination can lead to a reduction in the occurrence of these types of malignoma. Treatment of preneoplastic lesions is found in this manual as well as operative and radiooncological treatment of the malignomas.



Support for daily clinical practice
The "Malignomas of the vulva and vagina" manual was compiled by an interdisciplinary team in consideration of the current data situation. The aim was to formulate clear guidelines for diagnostics, therapy and aftercare for malignomas of the vulva and vagina which can provide support in daily clinical practice.



Critical discussion makes individual decisions easier
The critical discussion and presentation of studies in this area should make the background to recommendations more comprehensible and make individual decisions easier, particularly in difficult situations.



The third most common genital tumour in women
Cervical carcinoma is the third most common genital tumour in women. Through an HPV vaccination the development of cervical dysplasias and invasive carcinomas can be prevented. Effective, early detection of cancer is possible via a cytological smear. Treatment generally takes place via an operation and in some cases this is followed by radiotherapy or radiochemotherapy.

The most common genital tumour in women
Carcinoma of the uterine corpus, corpus carcinoma or endometrial carcinoma is the most common genital tumour in women. Operative therapy is the method of choice, also because the best prognosis factors can be recorded using this method.



Interdisciplinary and practice-orientated
This manual has been compiled on an interdisciplinary basis. It offers practice-orientated and implementable information, therapy recommendations based on the latest study data as well as support for daily clinical practice.